Skip to main content

Table 3 Access to information about diagnosis, treatment, consequences and complications (N = 174)

From: Access to information and counselling – older cancer patients’ self-report: a cross-sectional survey

 

Information about diagnosis and treatmenta

Information about consequences and complicationsa

Mean (SD)

p-value (ES)

Mean (SD)

p-value (ES)

Gender

 Women

3.33 (1.4)

 

3.69 (1.3)

 

 Men

3.07 (1.3)

0.26

3.20 (1.2)

0.03

Age

 66–74 years

3.10 (1.5)

 

3.46 (1.4)

 

 75–84 years

3.17 (1.3)

 

3.38 (1.3)

 

 ≥ 85 years

3.56 (1.4)

0.35

3.75 (1.2)

0.45

Civil status

 Married/cohabiting

3.32 (1.3)

 

3.58 (1.3)

 

 Single

3.12 (1.4)

0.38

3.37 (1.4)

0.33

Education

 > 13 years

2.91 (1.2)

 

3.21 (1.3)

 

 ≤ 13 years

3.12 (1.4)

0.10

3.57 (1.3)

0.15

Norwegian region

 West

3.55 (1.3)

 

3.75 (1.3)

 

 East

3.09 (1.4)

0.07

3.36 (1.3)

0.11

Cancer diagnosis

 Breast

3.86 (1.3)

0.20

4.17 (1.2)

0.19

 Lung

2.92 (1.6)

0.40

3.23 (1.4)

0.50

 Gynecological

3.57 (1.2)

0.30

4.23 (0.9)

0.008 (0.73)

 Prostate

2.88 (1.3)

0.28

2.94 (1.1)

0.05 (0.49)

 Hematological

3.89 (1.3)

0.02 (0.58)

3.94 (1.3)

0.09 (0.42)

 Colon/rectum

3.35 (1.6)

0.66

3.59 (1.5)

0.69

 Other

2.92 (1.3)

0.22

3.08 (1.3)

0.10

 Two or more cancer diagnoses

3.03 (1.2)

0.38

3.45 (1.3)

0.94

Functional level

 Normal

3.19 (1.4)

 

3.48 (1.4)

 

 Limited/poor

3.25 (1.4)

0.83

3.49 (1.3)

1.0

Comorbidity

 Yes

3.30 (1.4)

 

3.49 (1.3)

 

 No

3.10 (1.4)

0.38

3.46 (1.4)

0.88

Time since diagnosis

 > 1 year

3.33 (1.3)

 

3.59 (1.3)

 

 ≤ 1 year

3.04 (1.5)

0.23

3.29 (1.3)

0.20

Ongoing treatment

 Yes

3.16 (1.3)

 

3.35 (1.3)

 

 No

3.30 (1.4)

0.54

3.65 (1.3)

0.18

Home care nursing

 Yes

3.24 (1.3)

 

3.49 (1.3)

 

 No

3.17 (1.4)

0.80

3.41 (1.4)

0.77

Cancer coordinator

 Yes

3.04 (1.6)

 

3.35 (1.4)

 

 No

3.44 (1.3)

0.08

3.61 (1.2)

0.25

  1. aScale 1–5; higher scores represent a lower extent of access to information